CRO - May 2, 2022
Serendipity has been invited as a part owner of LINK Medical
Serendipity Partners (Serendipity) now owns 49% of the shares, however, Dr. Ola Gudmundsen will still hold the majority of the shares. The transaction is mainly structured as a share issue, where Serendipity provides growth capital to LINK Medical, states the company. Co-owners and long-term investors To enable further growth and provide new competencies to the […]
Clinical Trials - March 29, 2022
The new EU Clinical Trial Regulation: Key considerations
LINK Medical is currently preparing to work in line with the Clinical Trial Regulation, going into effect on the 31st of January 2022. The new regulation will replace the Clinical Trials Directive 2001/20/EC and aims to ensure a higher level of harmonization of the rules for authorizing and conducting clinical trials throughout the EU thus […]
Clinical Trials - June 30, 2021
LINK Medical and Ectin Research sign agreement
LINK Medical and Ectin Research have signed an agreement appointing LINK Medical Research to run the Phase I/II clinical study of the treatment of metastatic bladder cancer patients with the drug candidate MFA-370. Ectin Research aims to submit its clinical trial application (CTA) to the Swedish Medical Products Agency, in collaboration with LINK Medical, followed […]
Collaboration - May 25, 2021
LINK Medical and Medaffcon collaborate
LINK Medical and Medaffcon have announced their collaboration to provide customers with integrated, full-service Real World Evidence (RWE) and Market Access support across all Nordic countries. “We are excited to collaborate with LINK Medical and expand our RWE services across the Nordics, facilitating our customers with local knowledge and expertise. Through this collaboration we are […]
Acquisition - December 7, 2020
LINK Medical acquires IRW Consulting
LINK Medical has announced the acquisition of IRW Consulting AB, a Nordic CRO with more than 20 years of experience in clinical research outsourcing. With this acquisition LINK Medical will continue growing and strengthening its position in the Nordics while improving its already strong offerings and increasing its clinical operations capabilities in the region, the […]
New Market - April 2, 2020
LINK Medical Research opens London office
LINK Medical has announced the opening of its new UK office at MedCity, in London’s City region. The expansion to London will enable the company to bring significant value to UK-based biopharma and medtech companies by accelerating their product development, they state in their press release. The MedCity location was strategically chosen for its world-leading […]
